Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Short-term Investments: 2017-2025

Historic Short-term Investments for Organogenesis Holdings (ORGO) over the last 7 years, with Sep 2025 value amounting to $4.4 million.

  • Organogenesis Holdings' Short-term Investments rose 644.88% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 644.88%. This contributed to the annual value of $580,000 for FY2024, which is 16.47% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Short-term Investments of $4.4 million as of Q3 2025, which was down 17.44% from $5.3 million recorded in Q2 2025.
  • Organogenesis Holdings' Short-term Investments' 5-year high stood at $7.0 million during Q1 2025, with a 5-year trough of $487,000 in Q3 2021.
  • Its 3-year average for Short-term Investments is $2.0 million, with a median of $599,000 in 2023.
  • Its Short-term Investments has fluctuated over the past 5 years, first tumbled by 38.67% in 2023, then soared by 876.81% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Short-term Investments (Quarterly) stood at $599,000 in 2021, then soared by 35.56% to $812,000 in 2022, then tumbled by 38.67% to $498,000 in 2023, then climbed by 16.47% to $580,000 in 2024, then skyrocketed by 644.88% to $4.4 million in 2025.
  • Its Short-term Investments stands at $4.4 million for Q3 2025, versus $5.3 million for Q2 2025 and $7.0 million for Q1 2025.